ST
ARIA

Stifel Trust’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Stifel Trust’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3K Hold
400
– – ﹤0.01% 499
2014
Q2 		$3K Sell
400
-8,000
-95% -$55K ﹤0.01% 434
2014
Q1 		$68K Sell
8,400
-7,500
-47% -$58.4K 0.01% 246
2013
Q4 		$109K Buy
15,900
+400
+3% +$2.16K 0.02% 206
2013
Q3 		$286K Hold
15,500
– – 0.06% 160
2013
Q2 		$272K Buy
+15,500
New +$275K 0.06% 158

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Stifel Trust's ARIA Position: Q3 2014 in Review

Stifel Trust held its Ariad Pharmaceuticals Inc (ARIA) position steady in Q3 2014 at 400 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #499.

Stifel Trust first reported a position in ARIA in Q2 2013 and has held it in 6 quarters since. The position peaked at $286K in Q3 2013. 169 funds tracked by Wall St. Rank hold ARIA as of Q3 2014.

  • Stifel Trust held 400 shares of Ariad Pharmaceuticals Inc worth $3K as of Q3 2014.
  • Stifel Trust left its Ariad Pharmaceuticals Inc share count unchanged in Q3 2014.
  • Ariad Pharmaceuticals Inc made up ﹤0.01% of Stifel Trust's portfolio in Q3 2014, its #499 holding.
  • Stifel Trust first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and has held it in 6 quarters since.
  • Stifel Trust's Ariad Pharmaceuticals Inc position peaked at $286K in Q3 2013.
  • 169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.